Sponsored
Biosimilar Uptake in the US: Barriers, Breakthroughs, and Biologic Wars
Biosimilars, biologic products that are highly similar to already approved reference biologics, are reshaping the pharmaceutical landscape by offering cost-effective alternatives to high-priced biologics. While both the United States and the European Union recognize the value of biosimilars, their regulatory pathways, adoption rates, market penetration, and commercial challenges reveal distinct...
0 תגובות 0 שיתופים 269 צפיות 0 ביקורות
Sponsored
Sponsored
Sponsored